Title
Laboratory evaluation of a smartphone-based electronic reader of rapid dual point-of-care tests for antibodies to human immunodeficiency virus and treponema pallidum infections
Date Issued
01 January 2017
Access level
open access
Resource Type
journal article
Publisher(s)
Lippincott Williams and Wilkins
Abstract
Background: Dual point-of-care tests for antibodies to human immunodeficiency virus (HIV) and Treponema pallidum allow for same-day testing and treatment and have been demonstrated to be cost-effective in preventing the adverse outcomes of HIV infection and syphilis. By recording and transmitting data as they are collected, electronic readers address challenges related to the decentralization of point-of-care testing. Methods: We evaluated a smartphone-based electronic reader using 201 sera tested with 2 dual rapid tests for detection of antibodies to HIV and T. pallidum in Los Angeles, USA, and Lima, Peru. Tests were read both visually and with the electronic reader. Enzyme immunoassay followed by Western blot and T. pallidum particle agglutination were the reference tests for HIV and T. pallidum, respectively. Results: The sensitivities of the 2 rapid tests for detection of HIV were 94.1% and 97.0% for electronic readings. Both tests had a specificity of 100% for detection of HIV by electronic reading. The sensitivities of the 2 rapid tests for detection of T. pallidum were 86.5% and 92.4% for electronic readings. The specificities for detection of T. pallidum were 99.1% and 99.0% by electronic reading. There were no significant differences between the accuracies of visual and electronic readings, and the performance did not differ between the 2 study sites. Conclusions: Our results show the electronic reader to be a promising option for increasing the use of point-of-care testing programs.
Start page
412
End page
416
Volume
44
Issue
7
Language
English
OCDE Knowledge area
Inmunología Patología
Scopus EID
2-s2.0-85021450400
PubMed ID
Source
Sexually Transmitted Diseases
ISSN of the container
01485717
Sponsor(s)
This work was supported by the National Institutes of Health/National Institute of Allergy and Infectious Disease [R01AI099727]. Rapid tests were donated by Standard Diagnostics (Korea) and Premier Medical Corporation, Ltd. (India).
Sources of information: Directorio de Producción Científica Scopus